...
首页> 外文期刊>ACS applied materials & interfaces >pH/NIR-Responsive Polypyrrole-Functionalized Fibrous Localized Drug-Delivery Platform for Synergistic Cancer Therapy
【24h】

pH/NIR-Responsive Polypyrrole-Functionalized Fibrous Localized Drug-Delivery Platform for Synergistic Cancer Therapy

机译:pH / NIR响应滤萘酚官能化纤维局部药物输送平台,用于协同癌症治疗

获取原文
获取原文并翻译 | 示例

摘要

Localized drug-delivery systems (LDDSs) are a promising approach for cancer treatment because they decrease systematic toxicity and enhance the therapeutic effect of the drugs via site-specific delivery of active compounds and possible gradual release. However, the development of LDDS with rationally controlled drug release and intelligent functionality holds great challenge. To this end, we have developed a tailorable fibrous site-specific drug-delivery platform functionalized with pH- and near-infrared (NIR)-responsive polypyrrole (PPy), with the aim of cancer treatment via a combination of photothermal ablation and chemotherapy. First, a paclitaxel (PTX)-loaded polycaprolactone (PCL) (PCL-PTX) mat was prepared by electrospinning and subsequently in situ membrane surface-functionalized with different concentrations of PPy. The obtained PPy-functionalized mats exhibited excellent photostability and heating property in response to NIR exposure. PPy-coated mats exhibited enhanced PTX release in a pH 5.5 environment compared to pH 7.4. Release was further accelerated in response to NIR under both conditions; however, superior release was observed at pH 5.5 compared to pH 7.4, indicating a dual stimuli-responsive (pH and NIR) drug-delivery platform. More importantly, the 808 nm NIR irradiation enabled markedly accelerated PTX release from PPy-coated PCL-PTX mats and slowed and sustained release following termination of laser irradiation, confirming representative stepwise drug-release properties. PPy-coated PCL-PTX mats presented significantly enhanced in vitro and in vivo anticancer efficacy under NIR irradiation compared to PPy-coated PCL-PTX mats not exposed to NIR or uncoated mats (PCL-PTX). This study has thus developed a promising fibrous site-specific drug-delivery platform with NIR- and pH-triggering that notably utilizes PPy as a dopant for synergistic photothermal chemotherapy.
机译:本地化药物递送系统(LDDS)是癌症治疗的有希望的方法,因为它们可降低系统毒性,并通过基于特异性递送活性化合物和可能的逐渐释放来增强药物的治疗效果。然而,具有合理控制的药物释放和智能功能的LDD的发展具有出色的挑战。为此,我们开发了一种可定制的纤维位点特异性药物输送平台,其用pH-和近红外(NIR) - 夸张的聚吡咯(PPY)官能化,目的是通过光热消融和化疗的组合来治疗。首先,通过静电纺丝和随后用不同浓度的PPY表面官能化制备紫杉醇(PTX) - 加载的聚己内酯(PCL-PTX)垫。所获得的PPY官能化垫响应NIR暴露具有优异的光稳定性和加热性能。与pH 7.4相比,PPY涂层垫在pH 5.5环境中表现出pH 5.5环境中的增强型PTX释放。在两种条件下,释放率进一步加速;然而,与pH7.4相比,在pH5.5中观察到优异的释放,表明双刺激响应(pH和NIR)药物输送平台。更重要的是,808nm Nir辐射使得通过PPY涂覆的PCL-PTX垫释放出明显加速的PTX释放,并在激光照射终止后减慢和缓慢释放,确认代表性的逐步药物释放性能。与未暴露于NIR或未涂覆的垫(PCL-PTX)的PPY涂覆的PCL-PTX垫相比,涂覆的PPY涂层PCL-PTX垫在鼻腔辐射下呈现显着增强,并且在NIR辐射下进行了体内抗癌效果。因此,该研究制定了一种有前途的纤维位点特异性药物 - 输送平台,具有NIR-和pH-触发,可明显利用PPY作为协同光热化疗的掺杂剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号